With increasing competition, the way to gain market share in this quickly growing market is with innovative technology.
By exposing mice to a unique combination of light and sound, MIT neuroscientists have shown they can improve cognitive and memory impairments similar to those seen in Alzheimer’s patients.
Researchers at the University of South Australia have developed a microneedle patch with antibacterial properties to make vaccinations safer than traditional needles or other microneedles.
New research shows that an engineered model of human liver tissue can be used to investigate the effects of RNAi, helping to speed up the development of such treatments.
These were some of the most thought-provoking comments MD+DI editors heard from industry experts who spoke at MD&M West 2019.
A recent survey revealed a significant knowledge gap between patients’ satisfaction and providers’ perceived patient satisfaction with commonly prescribed migraine treatments, as well as a lack of knowledge about non-drug migraine treatments.
Medtronic announced preliminary results from PRODIGY, a prospective, multi-center study to identify people at high risk for opioid-induced respiratory depression, a form of respiratory compromise.
Three robotics experts at MD&M West looked at the iterative process of developing medical robotic tools and discussed valuable takeaways from watching the industry leader, Intuitive Surgical, rise to the top.
Victor Gura, MD, inventor of the Wearable Artificial Kidney, spoke at MD&M West about design considerations, obstacles, and goals involved with developing a portable dialysis device.
A student has won a global competition for her efforts to develop a synthetic material that could act as both a diagnostic and a therapeutic agent for bacterial toxins.
The magazine published a special January edition on "The Future of Medicine" highlighting innovative organs-on-chips research and technology.
The Vetex Thrombectomy Catheter is designed to remove wall-to-wall clot within the vein, in one procedure, and without thrombolytic drugs.
MIT researchers have discovered a way to potentially restore movement in patients with paralysis, or treat unwanted movements such as muscle tremor in Parkinson's patients.